| Literature DB >> 22075673 |
Claudio Legnani1, Clara Terzaghi, Enrico Borgo, Alberto Ventura.
Abstract
The aim of anterior cruciate ligament (ACL) reconstruction is essentially to restore functional stability of the knee and to allow patients to return to their desired work and activities. While in the young and active population, surgery is often the best therapeutic option after an ACL tear, ACL reconstruction in middle-aged people is rather more controversial due to concerns about a higher complication rate. The purpose of our article is to establish, through a systematic review of the literature, useful decision-making criteria for the management of anterior cruciate ligament rupture in patients aged 40 years and older, guiding surgeons to the most appropriate therapeutic approach. Various reports have shown excellent results of ACL reconstruction in patients over the age of 40 in terms of subjective satisfaction, return to previous activity level, and reduced complication and failure rates. Some even document excellent outcomes in subjects of 50 years and older. Although there are limited high-level studies, data reported in the literature suggest that ACL reconstruction can be successful in appropriately selected, motivated older patients with symptomatic knee instability who want to return to participating in highly demanding sport and recreational activities. Deciding factors are based on occupation, sex, activity level of the subject, amount of time spent performing such highly demanding activities, and presence of associated knee lesions. Physiological age and activity level are more important than chronological age as deciding factors when considering ACL reconstruction.Entities:
Mesh:
Year: 2011 PMID: 22075673 PMCID: PMC3225626 DOI: 10.1007/s10195-011-0167-6
Source DB: PubMed Journal: J Orthop Traumatol ISSN: 1590-9921
Summary of studies included in the present paper reporting results of ACL reconstruction in middle-aged patients
| Author | No. of patients | Level of evidence | Mean age (range) | Follow-up period (range) | Graft type |
|---|---|---|---|---|---|
| Barber et al. [ | 33 | II prospective clinical trial | 44 years (40–52) | 21 months (12–36) | 12 BPTB, 21 Allograft |
| Heier et al. [ | 45 | III retrospective cohort study | 44.6 years (40–62) | 37 months (24–96) | BPTB |
| Plancher et al. [ | 75 | III retrospective cohort study | 45 years (40–60) | 55 months (26–117) | BPTB |
| Viola et al. [ | 11 | III retrospective case–control study | 42.6 years (40–47) | 29 months (12–42) | BPTB |
| Brandsson et al. [ | 30 | III retrospective case–control study | 43 years (40–51) | 31 months (22–60) | BPTB |
| Zysk et al. [ | 102 | III retrospective case–control study | 46 years (40–59) | 29 months (12–46) | Primary suture with or without semitendinosus tendon augmentation |
| Kuechle et al. [ | 47 | III retrospective cohort study | 45 years (40.2–60.8) | 59.7 months (24–110) | Allograft |
| Barrett et al. [ | 63 | III retrospective cohort study | 47.13 years (40–58) Allograft | 36.4 months (24–74) Allograft | 38 Allograft, 25 BPTB |
| 44.52 years (40–54) BPTB | 44.4 months (24–99) BPTB | ||||
| Javernick et al. [ | 84 | III retrospective cohort study | 45 years (40-56) | 43 months (12–72) | Hamstrings |
| Marquass et al. [ | 28 | IV case series | 45.4 years (40–61) | 30.4 months (14–57) | Hamstrings |
| Khan et al. [ | 21 | IV case series | 44 years (40–56) | 24.5 months (12–37) | Hamstrings |
| Barber et al. [ | 11 | III retrospective case–control study | 44 years (40–56) | 35 months (24–58) | BPTB allograft |
| Blyth et al. [ | 31 | III retrospective cohort study | 54.5 years (50–66) | 46 months (24–95) | 10 BPTB, 21 hamstrings |
| Stein et al. [ | 19 | IV case series | 54 years (49–64) | 24 months (9–48) | Allograft |
| Dahm et al. [ | 35 | IV case series | 57 years (50–66) | 72 months (25–173) | 23 Allograft, 12 BPTB |
| Trojani et al. [ | 18 | IV case series | 57 years (51–66) | 31 months (12–59) | Hamstrings |
| Osti et al. [ | 20 | III retrospective case–control study | 56 years (50–62) | 32 months (24–49) | N/a |
N/a not available, BPTB bone-patellar tendon-bone
Results of subjective and objective evaluations
| Author | IKDC score | Lysholm score | Tegner score | Arthrometer (laxity ≤ 3 mm vs. normal knee) |
|---|---|---|---|---|
| Barber et al. [ | N/a | 95 | 5.7 | 15 (79%) |
| Heier et al. [ | A: 4 B: 25 C: 14 D: 2 | 91 | N/a | 31 (78%) |
| Plancher et al. [ | A: 21 B: 49 C: 5 D: 0 | 94 | N/a | 50 (67%) |
| Viola et al. [ | A: 1 B: 8 C: 2 D: 0 | 88.5 | 5.3 | 7 (64%) |
| Brandsson et al. [ | A: 10 B: 12 C: 6 D: 2 | 91 | 5 | 21 (70%) |
| Zysk et al. [ | N/a | 88 Augmentation 80 Primary suture | N/a | 23 (66%) Primary suture 60 (90%) Augmentation |
| Kuechle et al. [ | N/a | 89.7 | N/a | 22 (81%) |
| Barrett et al. [ | N/a | 91 Allograft 92 BPTB | 4.1 Allograft 4.3 BPTB | 33 (86%) Allograft 24 (96%) BPTB |
| Javernick et al. [ | N/a | 94 | 5 | N/a |
| Marquass et al. [ | 83.4 | 91.5 | 4.5 | 16 (57%) |
| Khan et al. [ | 83 | 92 | 6 | 19 (90%) |
| Barber et al. [ | N/a | 88.8 | 6.6 | 10 (91%) |
| Blyth et al. [ | A: 5 B: 20 C: 6 D: 0 | 93 | 5.2 | 11 (41%) |
| Stein et al. [ | N/a | 92 | N/a | 18 (95%) |
| Dahm et al. [ | 90 | 92 | 4.3 | N/a |
| Trojani et al. [ | A: 7 B: 7 C: 3 D: 1 | N/a | N/a | N/a |
| Osti et al. [ | 91 | 89 | N/a | 15 (75%) |
N/a not available, IKDC International Knee Documentation Committee, BPTB bone-patellar tendon-bone
Complications and failure rates
| Author | Complications | Graft failures (%) |
|---|---|---|
| Barber et al. [ | 1 (3%) loss of postoperative motion | 0 (0) |
| Heier et al. [ | 1 (2%) loss of postoperative motion 1 (2%) anterior knee pain | 2 (4) |
| Plancher et al. [ | 4 (4%) hardware intolerances 1 (1%) patellar ligament inflammation 3 (3%) losses of postoperative motion | 0 (0) |
| Viola et al. [ | 1 (9%) loss of postoperative motion | 0 (0) |
| Brandsson et al. [ | 2 (6%) bleeding complications 8 (27%) losses of postoperative motion | 0 (0) |
| Zysk et al. [ | 1 (1%) bleeding complication 6 (6%) losses of postoperative motion 7 (6.9%) deep vein thromboses 1 (1%) lung embolism | 0 (0) |
| Kuechle et al. [ | 2 (4%) superficial wound infections 13 (28%) hardware intolerances 2 (4%) losses of postoperative motion | 1 (2) |
| Barrett et al. [ | 1 (2%) anterior knee pain 1 (2%) sterile synovitis | 1 (2) |
| Javernick et al. [ | 0 (0%) | 0 (0) |
| Marquass et al. [ | None reported | 0 (0) |
| Khan et al. [ | 1 (5%) superficial wound infection 1 (5%) deep vein thrombosis | 0 (0) |
| Barber et al. [ | None reported | 0 (0) |
| Blyth et al. [ | 2 (6%) wound healing problems | 0 (0) |
| Stein et al. [ | 2 (8%) recurrent knee effusions | 0 (0) |
| Dahm et al. [ | 2 (16%) hardware intolerances | 3 (9) |
| Trojani et al. [ | 3 (17%) losses of postoperative motion 1 (5%) posterior knee pain 4 (22%) cases of tibiofemoral pain | 0 (0) |
| Osti et al. [ | None reported | 1 (5) |